Summary:
The purpose of this study, which involves research, is to
determine whether the investigational drug, vonoprazan,
is safe and effective in the potential treatment of
symptomatic non-erosive gastroesophageal reflux
disease compared to a placebo.
Qualified Participants Must:
• You might qualify to participate if you have been experiencing frequent heartburn over the last six months
•
You must be at least 18 years old and will need to meet with a physician who is participating in this study to determine if you are fully eligible and if this study is right for you
Qualified Participants May Receive:
If you decide to participate in this study, you will be
asked to attend a total of 10 study visits (6 in person at
study location and 4 phone call contacts) over 33 weeks.
Your study physician will provide you with the study drug,
which could contain either active treatment or placebo,
and perform assessments to track your overall health
and progress throughout the study.
You will be compensated for time and travel for each visit!